Effects and mechanisms of natural alkaloids for prevention and treatment of osteoporosis

Effects and mechanisms of natural alkaloids for prevention and treatment of osteoporosis

Natural alkaloids are polycyclic, nitrogen-containing, and basic compounds obtained from plants. In this review, the advances in bioactive alkaloids with respect to their chemical structures, herbal sources, and effects for the prevention and treatment of osteoporosis are discussed. Anti-osteoporosi...

Full description

Bibliographic Details
Main Authors:	Bingfeng Lin, Pingcui Xu, Juan Zheng, Xuehui Deng, Qitao Ye, Zhongping Huang, Nani Wang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-09-01
Series:	Frontiers in Pharmacology
Subjects:	alkaloids osteoporosis osteoblasts osteoclasts NFκB MAPK
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2022.1014173/full

Similar Items

Total flavonoids from celery suppresses RANKL-induced osteoclast differentiation and bone resorption function via attenuating NF-κB and p38 pathways in RAW264.7 cells
by: Lujuan Jia, et al.
Published: (2020-06-01)

Sesamolin Protects Mice From Ovariectomized Bone Loss by Inhibiting Osteoclastogenesis and RANKL-Mediated NF-κB and MAPK Signaling Pathways
by: Xue Yang, et al.
Published: (2021-06-01)

Oroxin B Attenuates Ovariectomy-Induced Bone Loss by Suppressing Osteoclast Formation and Activity
by: Huang JM, et al.
Published: (2021-11-01)

Schisandrin B Inhibits Osteoclastogenesis and Protects Against Ovariectomy-Induced Bone Loss
by: Jia Wang, et al.
Published: (2020-07-01)

Tyloxapol inhibits RANKL-stimulated osteoclastogenesis and ovariectomized-induced bone loss by restraining NF-κB and MAPK activation
by: Wen Guo, et al.
Published: (2021-05-01)

Aconine attenuates osteoclast-mediated bone resorption and ferroptosis to improve osteoporosis via inhibiting NF-κB signaling
by: Chunchun Xue, et al.
Published: (2023-11-01)

Ginkgetin attenuates bone loss in OVX mice by inhibiting the NF-κB/IκBα signaling pathway
by: GeJin Wei, et al.
Published: (2024-07-01)

Chrysin Protects Against Titanium Particle-Induced Osteolysis by Attenuating Osteoclast Formation and Function by Inhibiting NF-κB and MAPK Signaling
by: Zuoxing Wu, et al.
Published: (2022-03-01)

Prevention and treatment of osteoporosis with natural products: Regulatory mechanism based on cell ferroptosis
by: Yunshang Yang, et al.
Published: (2023-12-01)

Stigmasterol mitigates estrogen-deficiency-induced osteoporosis through inhibition of phosphorylated p65 and MAPK signaling pathways
by: Qiangqiang Zhao, et al.
Published: (2024-12-01)

Necroptosis: A new target for prevention of osteoporosis
by: Xinli Hu, et al.
Published: (2022-10-01)

Effects of Taxifolin on Osteoclastogenesis in vitro and in vivo
by: Cong Cai, et al.
Published: (2018-11-01)

NLRP3 Inflammasome: A New Target for Prevention and Control of Osteoporosis?
by: Na Jiang, et al.
Published: (2021-09-01)

Exploring the role and mechanism of Fuzi decoction in the treatment of osteoporosis by integrating network pharmacology and experimental verification
by: Fudong Li, et al.
Published: (2023-07-01)

Melatonin prevents cadmium-induced osteoporosis by affecting the osteoblast and osteoclast differentiation and pyroptosis in duck
by: Yonggang Ma, et al.
Published: (2024-09-01)

Aspirin prevents estrogen deficiency-induced bone loss by inhibiting osteoclastogenesis and promoting osteogenesis
by: Yongyun Chang, et al.
Published: (2023-03-01)

Acacetin Prevents Bone Loss by Disrupting Osteoclast Formation and Promoting Type H Vessel Formation in Ovariectomy-Induced Osteoporosis
by: Xiao Lin, et al.
Published: (2022-04-01)

Ulinastatin Inhibits Osteoclastogenesis and Suppresses Ovariectomy-Induced Bone Loss by Downregulating uPAR
by: Jun-ming Huang, et al.
Published: (2018-09-01)

The effect of cytokines on osteoblasts and osteoclasts in bone remodeling in osteoporosis: a review
by: Jie Xu, et al.
Published: (2023-07-01)

Peiminine Suppresses RANKL-Induced Osteoclastogenesis by Inhibiting the NFATc1, ERK, and NF-κB Signaling Pathways
by: Mengbo Zhu, et al.
Published: (2021-09-01)

Berbamine inhibits RANKL- and M-CSF-mediated osteoclastogenesis and alleviates ovariectomy-induced bone loss
by: Guobin Qi, et al.
Published: (2022-11-01)

Protective effects of curcumin against osteoporosis and its molecular mechanisms: a recent review in preclinical trials
by: Shenglei Yang, et al.
Published: (2023-09-01)

POSTMENOPAUSAL OSTEOPOROSIS – AN EXPLORATIVE LITERATURE REVIEW
by: Iulian Ștefan HOLUBIAC, et al.
Published: (2019-12-01)

A Novel Small Molecule Which Increases Osteoprotegerin Expression and Protects Against Ovariectomy-Related Bone Loss in Rats
by: Xiaowan Han, et al.
Published: (2019-03-01)

Role of histone modification in the occurrence and development of osteoporosis
by: Pan Sun, et al.
Published: (2022-08-01)

Evolving Roles of Natural Terpenoids From Traditional Chinese Medicine in the Treatment of Osteoporosis
by: Yue Zhuo, et al.
Published: (2022-05-01)

The role of cytokines in bone remodeling and the pathogenesis of postmenopausal osteoporosis
by: G. A. Ignatenko, et al.
Published: (2020-06-01)

Research progress of circRNA as a biomarker of osteoporosis
by: Xing Du, et al.
Published: (2024-05-01)

The Potential of Natural Compounds Regulating Autophagy in the Treatment of Osteoporosis
by: Zhao Y, et al.
Published: (2023-12-01)

Geniposide suppressed OX-LDL-induced osteoblast apoptosis by regulating the NRF2/NF-κB signaling pathway
by: Yaosheng Xiao, et al.
Published: (2023-08-01)

Jin-Tian-Ge ameliorates ovariectomy-induced bone loss in rats and modulates osteoblastogenesis and osteoclastogenesis in vitro
by: Yi Shen, et al.
Published: (2022-10-01)

Oligosaccharides from Sargassum thunbergii inhibit osteoclast differentiation via regulation of IRF-8 signaling
by: Weihua Jin, et al.
Published: (2023-02-01)

Punicalin Attenuates Breast Cancer-Associated Osteolysis by Inhibiting the NF-κB Signaling Pathway of Osteoclasts
by: Tao Li, et al.
Published: (2021-11-01)

Unveiling the potential of Butylphthalide: inhibiting osteoclastogenesis and preventing bone loss
by: Feng Yanbin, et al.
Published: (2024-02-01)

Cimifugin Suppresses NF-κB Signaling to Prevent Osteoclastogenesis and Periprosthetic Osteolysis
by: Juan Duan, et al.
Published: (2021-09-01)

Nanohydroxyapatite (nHAp) Doped with Iron Oxide Nanoparticles (IO), miR-21 and miR-124 Under Magnetic Field Conditions Modulates Osteoblast Viability, Reduces Inflammation and Inhibits the Growth of Osteoclast – A Novel Concept for Osteoporosis Treatment: Part 1
by: Marycz K, et al.
Published: (2021-05-01)

The molecular etiology and treatment of glucocorticoid-induced osteoporosis
by: Cheng-Huan Peng, et al.
Published: (2021-01-01)

Sanggenon C Stimulates Osteoblastic Proliferation and Differentiation, Inhibits Osteoclastic Resorption, and Ameliorates Prednisone-Induced Osteoporosis in Zebrafish Model
by: Huijuan Wang, et al.
Published: (2018-09-01)

Stevioside Prevents Wear Particle-Induced Osteolysis by Inhibiting Osteoclastogenesis and Inflammatory Response via the Suppression of TAK1 Activation
by: Jiahong Meng, et al.
Published: (2018-09-01)

Osteoporosis: interferon-gamma-mediated bone remodeling in osteoimmunology
by: Siying Li, et al.
Published: (2024-05-01)